{"slug":"semaglutide-chemo-neuropathy","verification":{"valid":true,"entries":4,"head":"3aad3135b48443f405859c5157796d625824aa126db4b65b05182df1cc3759b1"},"count":4,"sources":[{"id":"s0","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8550712/","title":"Diabetes mellitus as a risk factor for chemotherapy-induced peripheral neuropathy","quote":"Meta-analysis showed that there was a statistically significant positive correlation between DM and CIPN (odds ratio [OR] = 1.60...","summary":"Human meta-analysis linking diabetes to higher CIPN risk.","claim_ids":["c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T00:30:00.676Z","link_status":"ok","quote_status":"unverified","prev":"genesis","hash":"c70e9c73fab595527c86ea3dad591704647354ea7b43784e26c305e83d05aafa"},{"id":"s10","type":"pubmed","url":"https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.23008","title":"Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy","quote":"This trial failed to demonstrate any benefit to using gabapentin to treat symptoms caused by CIPN.","summary":"RCT showing no CIPN benefit for gabapentin.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T00:30:00.676Z","link_status":"ok","quote_status":"unverified","prev":"c70e9c73fab595527c86ea3dad591704647354ea7b43784e26c305e83d05aafa","hash":"c0e3948cd332ee5684746cccb5a2c3885116485084cda8e9803f1dce51decdb1"},{"id":"s14","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11593193/","title":"Semaglutide Ameliorates Diabetic Neuropathic Pain by Inhibiting Neuroinflammation in the Spinal Cord","quote":"The findings of our research demonstrate that SEMA significantly alleviates DNP-induced mechanical allodynia and thermal hyperalgesia.","summary":"Rat study on semaglutide for diabetic neuropathy pain.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T00:30:00.676Z","link_status":"ok","quote_status":"unverified","prev":"c0e3948cd332ee5684746cccb5a2c3885116485084cda8e9803f1dce51decdb1","hash":"1a7ffd6d022124928fbf3c9deae64b8388016f690bef3dd64ae2d5ea51b40f75"},{"id":"s21","type":"pubmed","url":"https://jamanetwork.com/journals/jamaophthalmology/fullarticle/2820255","title":"Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide","quote":"This matched cohort study of 16 827 patients revealed higher risk of NAION in patients prescribed semaglutide compared with patients prescribed non–glucagon-like peptide-1 receptor agonist medications.","summary":"Human cohort on semaglutide and optic neuropathy risk.","claim_ids":["c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T00:30:00.676Z","link_status":"http_403","quote_status":"unverified","prev":"1a7ffd6d022124928fbf3c9deae64b8388016f690bef3dd64ae2d5ea51b40f75","hash":"3aad3135b48443f405859c5157796d625824aa126db4b65b05182df1cc3759b1"}]}